Andrew Pucker, OD, PhD, FAAO, FSLS, FBCLA, discussed how oculomics research presented at AAOpt 2026 could eventually support point-of-care diagnosis and referral decisions.
|Articles|November 12, 2021
Poll results: What pipeline presbyopia treatment are you most looking forward to?
Author(s)Brooke Henson, Editor
See our latest poll results
Advertisement
Optometry Times® polled our audience with the following question from October 22, 2021 to November 5, 2021:
The poll appeared on
81 ODs responded, in total. Of these:
- 1 responded "Orasis CSF-1"
- 5 responded "Allergan AGN-190584 drop"
- 3 responded "Eyenovia MicroLine drop"
- 1 responded "Presbyopia Therapies PRX-100"
- 2 responded "Ocuphire Pharma Nyxol"
- 69 responded "Visus Therapeutics Brimochol"
Advertisement
Related to this article
Maria Sampalis, OD, discusses her implementation of the EHR software Barti in her practice.
Host Hamza Shah, OD, MS, FAAO, is joined by Cory Lappin, OD, MS, FAAO, to discuss dynamic muscle stimulation for dry eye, spurred by a paper on improving blinking in dry eye patients.
Maria Sampalis, OD, tells Diana Canto-Sims, OD, in this week's episode that the biggest impact AI has made at her practice is when used in the exam room as a scribe for routine patients.
The company reported that Acuvue Oasys Max 1-Day and Oasys 1-Day outperformed the other 5 daily disposable lenses evaluated in a recent study, among other Johnson & Johnson data highlights at AAOpt 2026.
Sharon Fekrat, MD, FACS, FASRS, of Duke University, discusses how retinal imaging fits into the diagnostic picture for CVI, TBI, and neurodegenerative disease, and when eye care professionals should suspect a neurological cause.
Lloyd Williams, MD, PhD, discusses rising cataract blindness and low-cost surgery in conflict zones for World Sight Day.
A handful of eye care providers spoke on the factors that have led to a lack of eye care access for World Sight Day.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
AAOpt 2026: Optimizing the ocular surface for cataract/refractive surgery: A case study
2
What is the biggest barrier to eye care access worldwide?
3
AAOpt 2026: Photobiomodulation to revolutionize dry AMD treatment, Dr Rafieetary says
4
AAOpt 2026: Brimonidine-hyaluronic acid drop sustains redness relief through 10 hours
5